Mercy Gilbert Medical Center

BIOTRONIK and IMDS Join Forces to Launch Innovative Micro Rx Catheter

Retrieved on: 
Thursday, February 8, 2024

BUELACH, Switzerland, Feb. 8, 2024 /PRNewswire/ -- BIOTRONIK is proud to introduce the Micro Rx™ catheter, a novel rapid exchange microcatheter developed to easily enhance guidewire support during percutaneous coronary interventions (PCI). This cutting-edge device, exclusively distributed by BIOTRONIK, is manufactured by IMDS (Interventional Medical Device Solutions). Micro Rx catheter marks the fourth IMDS product BIOTRONIK has brought to the U.S., creating a compelling portfolio of devices which includes NHancer Rx, TrapIT, and ReCross catheters.

Key Points: 
  • This cutting-edge device, exclusively distributed by BIOTRONIK, is manufactured by IMDS (Interventional Medical Device Solutions).
  • Micro Rx catheter marks the fourth IMDS product BIOTRONIK has brought to the U.S., creating a compelling portfolio of devices which includes NHancer Rx, TrapIT, and ReCross catheters.
  • The Micro Rx catheter is commercially available today in the United States and in March 2024 in Canada.
  • "IMDS has invested its expertise and dedication into the development of the Micro Rx catheter, with a specific focus on alleviating challenges in PCI," said Ryan Walters, President at BIOTRONIK USA.

$112 Million Multifamily Asset Sale and Financing Brokered by Institutional Property Advisors

Retrieved on: 
Monday, September 18, 2023

Institutional Property Advisors (IPA) , a division of Marcus & Millichap (NYSE:MMI) , announced today the sale of Aiya, a 360-unit multifamily asset in Gilbert, Arizona.

Key Points: 
  • Institutional Property Advisors (IPA) , a division of Marcus & Millichap (NYSE:MMI) , announced today the sale of Aiya, a 360-unit multifamily asset in Gilbert, Arizona.
  • The property sold for $112 million, or $311,111 per unit.
  • Gebing and Cliff David, IPA executive managing director, represented the seller, The Wolff Company, and procured the buyer, Olympus Property.
  • IPA Capital Markets executive director Brian Eisendrath and senior directors Cameron Chalfant and Jake Vitta arranged the acquisition financing.

Stemedica Initiating Phase IIb/III Clinical Trial for Patients with Chronic Ischemic Stroke

Retrieved on: 
Thursday, January 19, 2023

Stemedica plans to initiate a Phase IIb/III, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of a single intravenous injection of allogeneic mesenchymal stem cells to subjects with ischemic stroke.

Key Points: 
  • Stemedica plans to initiate a Phase IIb/III, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of a single intravenous injection of allogeneic mesenchymal stem cells to subjects with ischemic stroke.
  • Stemedica successfully completed a Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke in patients with chronic ischemic stroke and demonstrated an excellent safety profile of itMSCs.
  • We hope to bring this medication to patients with this debilitating condition,” said Dr. Lev Verkh, Chief Regulatory and Clinical Development Officer.
  • “Unlike other stroke trials using stem cells, this is the first clinical trial of its kind, evaluating Stemedica’s itMSCs.

Dignity Health, Lifepoint Rehabilitation Celebrate Opening of New Rehabilitation Hospital in Gilbert

Retrieved on: 
Wednesday, December 21, 2022

Dignity Health and Lifepoint Rehabilitation, a business unit of Lifepoint Health, are celebrating the opening of Dignity Health East Valley Rehabilitation Hospital – Gilbert, a 50,000-square-foot inpatient rehabilitation hospital.

Key Points: 
  • Dignity Health and Lifepoint Rehabilitation, a business unit of Lifepoint Health, are celebrating the opening of Dignity Health East Valley Rehabilitation Hospital – Gilbert, a 50,000-square-foot inpatient rehabilitation hospital.
  • View the full release here: https://www.businesswire.com/news/home/20221221005563/en/
    Dignity Health East Valley Rehabilitation Hospital – Gilbert is a 50,000-square-foot, 40-bed rehabilitation hospital.
  • “We are proud to advance our partnership with Dignity Health to increase access to these much-needed rehabilitation services in the East Valley and beyond.”
    Under the terms of the joint venture creating Dignity Health East Valley Rehabilitation Hospital, both Lifepoint Rehabilitation and Dignity Health are stake holders.
  • In addition to the newest Gilbert facility, Lifepoint Rehabilitation operates more than 30 freestanding inpatient rehabilitation facilities (IRFs) across 18 states, including Dignity Health East Valley Rehabilitation in Chandler, Ariz.

Phoenix Children's Launches Division of Anesthesiology, Names Leadership Team

Retrieved on: 
Tuesday, December 20, 2022

PHOENIX, Dec. 20, 2022 /PRNewswire/ -- Phoenix Children's, one of the nation's fastest-growing pediatric health systems, has announced the creation of a new Division of Anesthesiology and named Dr. Narasimhan "Sim" Jagannathan as Division Chief and Dr. Amod Sawardekar as Associate Division Chief.

Key Points: 
  • PHOENIX, Dec. 20, 2022 /PRNewswire/ -- Phoenix Children's , one of the nation's fastest-growing pediatric health systems, has announced the creation of a new Division of Anesthesiology and named Dr. Narasimhan "Sim" Jagannathan as Division Chief and Dr. Amod Sawardekar as Associate Division Chief.
  • Joining the newly created Division of Anesthesiology are 39 experienced providers who recently transitioned from a longstanding private practice into Phoenix Children's Medical Group.
  • This team is already an integral part of daily care delivery, having practiced extensively within Phoenix Children's health system.
  • In addition to the Division of Anesthesia, Phoenix Children's recently created a Division of Infectious Diseases and a Division of Nephrology and announced leadership appointments in each.

Phoenix Children's Creates New Center for Cleft and Craniofacial Care, Welcomes Nine New Providers

Retrieved on: 
Monday, December 19, 2022

PHOENIX, Dec. 19, 2022 /PRNewswire/ -- Phoenix Children's, one of the nation's fastest-growing pediatric health systems, today announced the creation of the Phoenix Children's Center for Cleft and Craniofacial Care .

Key Points: 
  • PHOENIX, Dec. 19, 2022 /PRNewswire/ -- Phoenix Children's, one of the nation's fastest-growing pediatric health systems, today announced the creation of the Phoenix Children's Center for Cleft and Craniofacial Care .
  • Nine medical providers specializing in cleft and craniofacial care, formerly of Barrow Neurological Institute's Cleft and Craniofacial Center, have joined Phoenix Children's Medical Group (PCMG) as part of this transition.
  • "Phoenix Children's clinicians have worked side-by-side with this cleft and craniofacial team for many years," said Daniel Ostlie, MD , surgeon in chief at Phoenix Children's.
  • The creation of Phoenix Children's Center for Cleft and Craniofacial Care comes during a time of significant growth for Phoenix Children's.

Phoenix Children's Names Leading Surgeon-Scientist Matthew Halanski, MD, Division Chief of Orthopedics and Sports Medicine

Retrieved on: 
Tuesday, November 29, 2022

PHOENIX, Nov. 29, 2022 /PRNewswire/ -- Phoenix Children's , one of the fastest-growing pediatric healthcare systems in the country, today announced the appointment of internationally renowned surgeon-scientist Matthew Halanski, MD, as Division Chief of Orthopedics and Sports Medicine.

Key Points: 
  • PHOENIX, Nov. 29, 2022 /PRNewswire/ -- Phoenix Children's , one of the fastest-growing pediatric healthcare systems in the country, today announced the appointment of internationally renowned surgeon-scientist Matthew Halanski, MD, as Division Chief of Orthopedics and Sports Medicine.
  • Dr. Halanski will lead the Herbert J. Louis Center for Orthopedics and Sports Medicine at Phoenix Children's .He is a prolific surgeon, researcher and professor in the fields of pediatric orthopedics and sports medicine .
  • Indeed, the Herbert J. Louis Center for Orthopedics and Sports Medicine regularly receives high rankings in U.S. News & World Report's "Best Children's Hospital" list.
  • Phoenix Children's Care Network includes more than 1,175 pediatric primary care providers and specialists who deliver care across more than 75 subspecialties.

Phoenix Children's Names Associate Surgeon in Chief of Phoenix Children's Hospital - East Valley

Retrieved on: 
Tuesday, November 22, 2022

PHOENIX, Nov. 22, 2022 /PRNewswire/ -- Phoenix Children's recently named Kathleen van Leeuwen, MD, associate surgeon in chief of Phoenix Children's Hospital – East Valley, slated to open in 2023. Dr. van Leeuwen is recognized in her field as an outstanding physician and surgeon and, as a longtime resident and active community member in the East Valley, she has worked and lived alongside the families Phoenix Children's serves.

Key Points: 
  • PHOENIX, Nov. 22, 2022 /PRNewswire/ -- Phoenix Children's recently named Kathleen van Leeuwen, MD , associate surgeon in chief of Phoenix Children's Hospital East Valley, slated to open in 2023.
  • Phoenix Children's East Valley Campus encompasses the planned hospital and two specialty care clinic sites, one of which is already open.
  • Phoenix Children's Hospital East Valley is a 367,341-square-foot, state-of-the-art facility that will offer 48 pediatric beds, a 24-bed emergency department, surgical services and diagnostic imaging.
  • In addition, construction is underway at Phoenix Children's Hospital Arrowhead Campus in Glendale and Phoenix Children's Avondale Campus .

Phoenix Children's Achieves Association for the Accreditation of Human Research Protection Programs Accreditation Signifying Highest Ethical Standards in Research

Retrieved on: 
Monday, November 21, 2022

PHOENIX, Nov. 21, 2022 /PRNewswire/ -- Phoenix Children's, one of the nation's largest pediatric health systems, has been recognized by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for its ethical research and comprehensive protections for research participants. The health system is one of just four Arizona healthcare organizations, and one of just 15 children's hospitals nationwide, to currently hold this accreditation.

Key Points: 
  • AAHRPP, a non-profit accrediting body, is considered the gold standard for ethical research, and this accreditation signals Phoenix Children's human research protection program exceeds the safeguards required by the U.S. government and prioritizes safety, quality and excellence in its practices.
  • "Our goal is to find new treatments for devastating childhood illnesses while protecting the children who make scientific advances possible."
  • The accreditation process spanned more than two years and included a comprehensive self-assessment and written application, as well as a site visit from AAHRPP human research protections administrators.
  • Following the visit, Phoenix Children's implemented the group's recommendations to ensure all aspects of the health system's research program align with AAHRPP's rigorous standards for protecting human research participants.

Phoenix Children's Launches Division of Infectious Diseases, Names Chief

Retrieved on: 
Tuesday, November 1, 2022

PHOENIX, Nov. 1, 2022 /PRNewswire/ -- In a move to further enhance the award-winning health system's ability to provide specialized care for children at high risk of infection, Phoenix Children's created a new Division of Infectious Diseases and named Wassim Ballan, MD, chief of the division.

Key Points: 
  • "As Phoenix Children's grows its physical footprint, we have a responsibility to continue providing world-class, highly personalized care, on an even larger scale," said Jared Muenzer , MD, MBA, physician-in-chief of Phoenix Children's and chief operating officer of Phoenix Children's Medical Group.
  • Indeed, the COVID-19 pandemic heightened the demand for infectious diseases clinicians and prompted the creation of this new division to bring more specialty care into the Phoenix Children's Medical Group.
  • The team has decades of experience in infection prevention and control, infectious diseases and managing infections in patients with weakened immune systems.
  • "Our team of pediatric infectious diseases specialists has provided care for patients at Phoenix Children's for more than a decade, and we are honored to officially join the Phoenix Children's Medical Group," said Dr. Ballan.